Literature DB >> 24574312

Analysis of AM-2201 and metabolites in a drugs and driving case.

Albert A Elian1, Jeffery Hackett.   

Abstract

This case report describes the analysis of AM-2201 in plant material and its metabolites in human urine obtained from an operator of a motor vehicle in the United States. The samples were taken from the driver because of his illegal driving activities and, his subsequent erratic behaviour. The AM-2201 was extracted from a sample of plant material by sonicating it in methanol, after which an aliquot was taken and diluted with aqueous phosphate buffer (pH 6) and extracted by solid-phase extraction using a C8/aminopropyl SPE cartridge. The cartridges were washed, dried, and eluted with ethyl acetate- methanol solvent system. The urine sample was hydrolyzed with β-glucuronidase at pH 6.8 before being diluted with aqueous phosphate buffer (pH 6) and extracted with the same type of SPE cartridge. After evaporation of the eluates, the samples were dissolved in mobile phase for analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Analysis of the plant material determined the concentration to be 0.05% (AM2201) by mass of dry material. The concentration of AM-2201 (AM2201-N-(4-hydroxypentyl ) metabolite in the urine was found to be 3.1 ng/ml. The urine also contained 109 ng/ml of delta-9-tetrahydrocannabinol carboxylic acid but no other drugs including JWH-018 metabolites.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  AM-2201; Driving; Drugs; Forensic; SPE

Mesh:

Substances:

Year:  2013        PMID: 24574312     DOI: 10.1002/dta.1535

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  2 in total

1.  Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats.

Authors:  Jeremy Carlier; Ariane Wohlfarth; Bonita D Salmeron; Karl B Scheidweiler; Marilyn A Huestis; Michael H Baumann
Journal:  J Pharmacol Exp Ther       Date:  2018-09-28       Impact factor: 4.030

2.  Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Jeremy Carlier; Karl B Scheidweiler; Ariane Wohlfarth; Bonita D Salmeron; Michael H Baumann; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2016-05-06       Impact factor: 4.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.